Sight Operating Margin from 2010 to 2024
| SGHT Stock | USD 6.51 0.06 0.91% |
Check Sight Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sight Sciences' main balance sheet or income statement drivers, such as Tax Provision of 74.8 K, Interest Income of 0.0 or Depreciation And Amortization of 858.2 K, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0 or PTB Ratio of 2.19. Sight financial statements analysis is a perfect complement when working with Sight Sciences Valuation or Volatility modules.
Sight | Operating Margin |
Latest Sight Sciences' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Sight Sciences over the last few years. It is Sight Sciences' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sight Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.59) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Sight Operating Margin Regression Statistics
| Arithmetic Mean | (1.53) | |
| Coefficient Of Variation | (31.54) | |
| Mean Deviation | 0.44 | |
| Median | (1.90) | |
| Standard Deviation | 0.48 | |
| Sample Variance | 0.23 | |
| Range | 1.1921 | |
| R-Value | 0.87 | |
| Mean Square Error | 0.06 | |
| R-Squared | 0.75 | |
| Significance | 0.000029 | |
| Slope | 0.09 | |
| Total Sum of Squares | 3.26 |
Sight Operating Margin History
About Sight Sciences Financial Statements
Sight Sciences shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Sight Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in Sight Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Sight Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was incorporated in 2010 and is headquartered in Menlo Park, California. Sight Sciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 212 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.